Many epidemics of water-borne hepatitis have occurred throughout India. These were thought to be epidemics of hepatitis A until 1980, when evidence for an enterically transmitted non-A, non-B hepatitis was first reported. Subsequently, hepatitis E virus was discovered and most recent dem of enterically ted non-A, non-B hepatitis have been attributed to hepatitis E virus infection. However, only a limited number of cases have been confirmed by immuno electron microscopy, polymerase chain reaction, or seroconversion. In the present study we have performed a retrospective seroepidemiologic study of 17 epidemics of waterborne hepatitis in India. We have confirmed that 16 of the 17 epidemics were caused at least in part by serologically closely related hepatitis E viruses. However, one epidemic, in the Andaman Islands, and possibly a signifnt minrit of cases in other epidemics, appears to have been caused by a previously unrecognized hepatitis agent.
Enterically transmitted water-borne hepatitis is recognized as a major public health problem in many developing countries (1) . The discovery of enterically transmitted non-A, non-B (ET-NANB) hepatitis, now designated hepatitis E, resulted from the use of highly sensitive and specific assays for the diagnosis of hepatitis A and hepatitis B to exclude these latter two types of hepatitis as the cause of several epidemics of water-borne hepatitis in India (2, 3) . Although the disease was discovered in 1980 (2, 3) it was not until 1983 that the putative etiologic agent, hepatitis E virus (HEV), was visualized by immuno electron microscopy (IEM) and IEM was used to establish the serologic uniqueness of this agent and to confirm its transmission to humans and nonhuman primates (4). However, a major impediment to progress in the study of HEV was the paucity of virus that could be obtained from feces of patients and experimentally infected primates for use as an antigen in serologic tests. In 1990, Reyes et al. (5) cloned and sequenced part of the HEV genome. Subsequently, an enzyme-linked immunosorbent assay (ELISA) was developed that used recombinant proteins expressed in Escherichia coli from open reading frames (ORFs) 2 and 3 of HEV as the source of antigen (6) . Recently, Tsarev et al. (7) developed an ELISA for the detection of IgM and IgG antibodies to HEV (anti-HEV) that uses a recombinant protein expressed in insect cells from ORF-2 of HEV as the source of antigen. This assay is highly sensitive and specific for the diagnosis of HEV infections and therefore useful for seroepidemiologic studies (8) .
In the past we have investigated 25 epidemics of waterborne viral hepatitis in India and have demonstrated that none of these was caused by hepatitis A virus (HAV). They were therefore classified as ET-NANB hepatitis. In the present study, we have revisited the question of the etiology ofET-NANB hepatitis by evaluating patients from 17 (1990) and were stored at -70°C.
PCR. Stool samples were tested in nested reverse transcription-PCRs as described (14, 15) . Sequencing and computer analyses were as described (15) .
Statistics. The x2 test for significance was employed. GMTs were calculated by using an arbitrary titer of 1:1 for the negative sera. were affected in the different epidemics and the patients in each epidemic reported they had not had clinical hepatitis during the previous epidemic(s). Serological studies conducted during the investigation of these 17 epidemics indicated a NANB etiology (refs. 2 and 9-12; unpublished data).
We used PCR specific for HEV to analyze a limited number of fecal samples collected from patients during six of the epidemics and were able to detect HEV genomes in seven samples and to amplify the ORF-3 region from three of the seven. By employing primers covering the entire ORF-3 region, we showed that there were no deletions in ORF-3 compared with the Burmese strain (16) in the three strains we studied, in contrast to a previous report of a 246-bp deletion in ORF-3 of Indian strains (17 Five serum samples from the Andaman epidemic previously had been tested for IgM anti-HEV by Western blot and two had been found to be weakly positive at a serum dilution of 1:20 (18) . Neither serum was positive by the present ELISA when tested at a dilution of 1:100, the dilution routinely employed for this assay (7) . To assure that we were not missing weak anti-HEV responses in these patients, we reanalyzed the data with a lower cutoff value for OD (0.2 vs. 0.35). Only two patients were weakly reactive (titer of 1:100) for IgM anti-HEV only, and two patients were similarly weakly reactive for IgG anti-HEV only. In addition, we retested all 75 sera at a 1:20 dilution for IgM and IgG anti-HEV by ELISA, using the standard cutoff value. Four additional test sera showed higher OD values, but a comparable number ofnegative control sera also showed similar OD values. The new samples with the high OD values did not include the two sera previously found to be positive by Western blot. Although the Western blot assay correlated well with the ELISA when samples from other epidemics were tested, we presume that the previous weak positive results with the Andaman samples were nonspecific. Since the vast majority of the Andaman sera were nonreactive in the ELISA, we conclude that the Andaman epidemic was not caused by an agent serologically related to HEV.
To ascertain whether the differences in prevalence of anti-HEV among the epidemics were due to variations in the interval between the onset of clinical symptoms and collection of blood samples, the data were analyzed by week after onset of illness (Fig. 3) age, at a time when they would be expected to be strongly positive for IgM and/or IgG anti-HEV, had their hepatitis been hepatitis E.
To determine whether the differences in percent ofpatients with serologic evidence of HEV infection in different epidemics were the result of serologic heterogeneity of HEV strains, leading to different sensitivities of the ELISA for different epidemics, we compared the titers of IgM anti-HEV for patients from different epidemics. As seen in Fig. 4 , the titers of IgM anti-HEV for patients from epidemics with low prevalences of anti-HEV positivity were indistinguishable from those of patients from epidemics with high prevalences of anti-HEV, indicating that the differences were probably not due to serologic variation among the epidemic strains of HEV.
As a further test of whether IgM anti-HEV-negative patients might actually have represented missed diagnoses of hepatitis E, we reinvestigated the serologic status of three patients with acute-phase sera that were negative for IgM anti-HEV and who had been rebled 41-77 days after onset of illness. These convalescent sera, from one patient in the Ahmedabad 1976 outbreak and two patients in the Kolhapur 1981 epidemic, were also negative for both IgM and IgG anti-HEV, thus confi-ming that these cases of hepatitis were indeed not etiologically related to known strains of HEV. Paired sera were not available from other anti-HEV-negative patients. However, from the absence of both IgM anti-HEV and high-titered IgG anti-HEV (-1:1000), we conclude that 44 patients from 13 of the remaining 16 epidemics may have had hepatitis not related to HEV ( Table 2 ). Ten of the 44 patients had low-titered IgG anti-HEV, but we have included them in the list of possible cases of non-E hepatitis because patients with low levels of IgG anti-HEV were found in a previous study to be protected against hepatitis E, probably by virtue of an infection with HEV at some time in the past (8) . Therefore, these 44 cases of hepatitis, occurring in conjunction with water-borne epidemics and not serologically related to any of the five recognized hepatitis viruses, may have been caused by a previously unrecognized hepatitis agent.
DISCUSSION
In 1980, Purcell and colleagues (2) reported evidence for a previously unrecognized hepatitis virus. This conclusion was based, in part, on a retrospective analysis of sera saved from the massive epidemic of water-borne hepatitis that occurred in Delhi in 1955-1956 (1) . Similarly, Khuroo (3) provided evidence that a previously unrecognized hepatitis agent was the cause of epidemic hepatitis in northern India. Both studies were based on exclusion of HAV and were made possible by the development of sensitive and specific serologic tests for HAV, the only water-borne hepatitis virus recognized at that time.
Subsequent to the identification of hepatitis E virus by IEM (4), attempts were made to characterize ET-NANB epidemics by this technique. Epidemics from India, Nepal, the former Union of Soviet Socialist Republics, Burma, Pakistan, Algeria, and Mexico were all shown to be associated with serologically related viruses. Only Doroshenko et al. (19) suggested that there was more than one agent causing epidemic ET-NANB hepatitis, based on the results of IEM.
In the present work, we have used a sensitive and specific test for anti-HEV to study 17 water-borne epidemics occurring in India during the past 38 years. We confirmed that the Delhi epidemic was, indeed, caused by HEV and showed that 15 of the other 16 epidemics studied were caused predominantly or exclusively by HEV, confirming that HEV is an important human pathogen in India. Although the current study encompassed epidemics of hepatitis caused by many different strains of HEV, the magnitudes and temporal relationships of the IgM and IgG anti-HEV responses were remarkably similar to those described by Bryan et al. (8) in the epidemic that occurred in Sargodha, Pakistan, in 1987. In that epidemic, from which the antigen used for ELISA in the present study was derived, 92% of 131 cases were identified as cases of hepatitis E. This suggests that most, if not all, epidemics of hepatitis E in this region are caused by serologically closely related strains of HEV. Similarly, in a study of three epidemics of NANB hepatitis in villages in Somalia, Mushahwar et al. (20) noted that 77.8-94% of patients were suffering from recent HEV infection. Although the expression systems were different in the two studies, the results obtained were remarkably similar (20) .
However, while underlining the importance of HEV infections in India, our data also suggested that some of these Indian epidemics may have been caused at least in part by a previously unrecognized agent that is spread by fecal-oral means. Evidence for such an agent came from several observations. First, the epidemics studied varied markedly in the proportion of hepatitis cases that could be ascribed to HEV. Most compelling was the absence of anti-HEV in As with hepatitis A and hepatitis E previously, the answers to many questions must await the development of sensitive and specific assays for the putative agent and antibodies to it. We presume that it is a virus, but its filterable nature has not yet been established. However, it is unlikely that such an agent is geographically restricted to India and evidence (by serologic exclusion) for its existence elsewhere should be sought. The data from the Doroshenko et al. (19) study of a Siberian epidemic, although limited, are consistent with results obtained in the present study. Further studies will be required to determine whether the putative new agent is a second serotype of HEV or an entirely different virus.
